CREX

Value Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 11.01 M9.73 M13.03 M10.55 M 44.32 M Gross profit 4.87 M4.45 M5.02 M4.78 M 19.12 M Operating expenses 5.58 M5.17 M6.35 M12.05 M 29.15 M Selling/general/admin expenses 5.58 M5.17 M6.35 M6.33 M 23.44 M Research & development ———— — Operating income -714 K-722 K-1.33 M-7.27 M -10.04 M Non-Operating Income, Total -2.24 M4.19 M-512 K-674 K 759 K Interest expense, net of interest capitalized 296 K321 K513 K530 K 1.66 M Non-Operating Income, excl. Interest Expenses -2.61 M4.13 M-1.03 M-1.06 M -567 K Unusual income/expense 74 K-265 K1 000-144 K -334 K Pretax income -2.96 M3.47 M-1.84 M-7.94 M -9.28 M Equity in earnings ———— — Taxes -120 K99 K-26 K-82 K -129 K Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -2.84 M3.37 M-1.82 M-7.86 M -9.15 M Discontinued operations ———— — Net income -2.84 M3.37 M-1.82 M-7.86 M -9.15 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -2.84 M3.37 M-1.82 M-7.86 M -9.15 M Basic earnings per share (Basic EPS) -0.280.32-0.17-0.75 -0.88 Diluted earnings per share (Diluted EPS) -0.280.32-0.17-0.75 -0.88 Average basic shares outstanding 10.44 M10.45 M10.5 M10.52 K 31.39 M Diluted shares outstanding 10.44 M10.45 M10.5 M10.52 K 31.39 M EBITDA 3.19 M440 K-141 K-6.07 M -2.58 M EBIT -714 K-722 K-1.33 M-7.27 M -10.04 M Cost of revenue 6.14 M5.28 M8.01 M5.77 M 25.21 M Other cost of goods sold 22 K18 K-4 000-5 000 31 K Depreciation & amortization (cash flow) 3.9 M1.16 M1.19 M1.2 M 7.45 M